THE NEWS & OBSERVER: Toyota, Bridgestone, Fujifilm: NC looks to attract more Japanese businesses this week
Gov. Roy Cooper and more than two dozen other North Carolina officials are in East Asia this week for the annual Southeastern United States/Japan Economic Development Conference. The goal of this Tokyo trip, Cooper said in a statement, is to recruit more Japanese industry. It is an effort the Tar Heel State has been making for 45 years.
THE NEWS & OBSERVER: NC GOP overturns 5 Cooper vetoes, as top Democrat accuses them of 'creating a monster'
North Carolina Republicans, wielding their veto-proof supermajority in the General Assembly on Tuesday, overturned vetoes from Democratic Gov. Roy Cooper one by one. They implemented a variety of controversial changes, stripping powers from the governor, advancing a pipeline project and overhauling election rules.
THE CAROLINA JOURNAL: Robinson proclaims "NC Solidarity with Israel Week"
Lt. Gov. Mark Robinson drew media attention Thursday morning after announcing that he would take steps as “acting governor” while N.C. Gov. Roy Cooper was in Japan this week for an economic development summit. In an event in the N.C. House auditorium, Robinson issued an official proclamation of a Day of Prayer and declaring this “North Carolina’s Solidarity with Israel Week.”
Healthcare
AP NEWS: North Carolina Medicaid expansion still set for Dec. 1 start as federal regulators give final OK
Federal regulators have given their final approval for North Carolina to begin offering Medicaid to hundreds of thousands of low-income adults on Dec. 1, state health officials announced on Friday. The Centers for Medicare & Medicaid Services told the state in a letter Thursday that changes to North Carolina’s Medicaid program to provide expanded coverage through the 2010 Affordable Care Act had been approved.
THE NEWS & OBSERVER: NC State Health Plan begins crackdown on spending for weight-loss drugs
The North Carolina State Health Plan will put new measures in place to prevent diabetes drugs like Ozempic from being used off-label for weight loss, leadership announced at a meeting Wednesday night. This is the plan’s first effort to rein in spending on a class of drugs called GLP-1s, which has put the plan’s finances “under siege.”